Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Examine the tax effects of rebalancing a portfolio and practical ways to minimize tax impact. This intro covers common scenarios and planning ideas.
21,738 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
Investing in eVTOLs isn’t just about flight tech. The real lever could be charging infrastructure. This guide explain...
In a year of sharp rotation, the Vanguard FTSE DEVELOPED Markets ETF ex US is outperforming the S&P 500—yet the decad...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
As Nvidia gears up for a pivotal fiscal 2027 Q1 print, investors are weighing AI demand, data center momentum, and ma...
A lithium-tech startup has joined the unicorn ranks after securing major funding and a government loan, underscoring ...
Barclays boosts its view on Charles Schwab after the firm guides for higher 2026 revenue and reports stronger Q1 resu...
CVS Health recently touched a fresh 52-week high after strong Q1 results. This deep dive explains why the rally may c...
A 2026 market shift is pushing workers away from chasing dozens of side gigs toward a lean, skill-driven playbook. Th...
An AI-driven forecast weighs XRP, Ethereum, and Solana to determine which could hit 10x first, factoring catalysts, l...